Steven Denbaars, Director at Akoustis Technologies, Inc. (AKTS), sold 36,508 shares at $6.15 ($224K) on 2018-03-15, disclosed to the SEC on 2018-03-19.
Open-market sale of $224k AKTS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.15 | 16,254 | $100K | 44.6% |
| 2 | $6.15 | 16,254 | $100K | 44.6% |
| 3 | $6.03 | 4,000 | $24K | 10.8% |
| Total | $6.14 avg | 36,508 | $224K | 100% |
| Filing → |
| PrivatePalomino Laboratories Inc. | BUY | 2026-04-20 | $50K | — | Filing → |
| ALMU | SELL | 2026-02-27 | $418K | — | Filing → |
| ALMU | BUY | 2025-05-23 | $100K | — | Filing → |